NEJM· @NEJM · X·· 2026-10-16精选AI 评分58
AI 导读
NEJM 以 Quick Take 视频形式总结了 3 期 HAELO 试验的研究结果,该试验评估体内基因编辑能否降低遗传性血管性水肿的发作率。遗传性血管性水肿是一种以严重肿胀为特征、可能危及生命的疾病,目前体内基因编辑对该病发作率的作用尚不明确。原文未披露具体疗效数据。
正文
Hereditary angioedema is a potentially life-threatening condition characterized by debilitating swelling. Whether in vivo gene editing could reduce attack rates is unclear. Research findings from the phase 3 HAELO trial are summarized in a new Quick Take video. https://nej.md/4s8GVgW
来源:NEJM · x.com